Mar 21, 2022

Implications of Opioid Lawsuits on Opioid Availability- Part 2

Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference, discusses the historic settlement in a multi-district opioid lawsuit in Texas. Pharmacy Times interviewed Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference and a lead negotiator for the many local districts participating in the historic settlement in a multi-district opioid lawsuit… Continue reading Implications of Opioid Lawsuits on Opioid Availability- Part 2

Mar 01, 2022

States Sprint Toward Deadline in $26B Opioid Deal Designed to Deliver ‘Global Peace’

Drug companies must decide by Friday whether to move forward with, or walk away from, funds that would compensate nearly all 50 states and U.S. territories for costs incurred by the opioid crisis.

Oct 26, 2021

Dallas County to receive $2.3 million from Johnson & Johnson in opioid settlement

Dallas County commissioners voted to accept a $2.3 million settlement Wednesday from pharmaceutical company Janssen, a subsidiary of Johnson & Johnson, over the toll of the opioid epidemic. The agreement is part of a global $26 billion settlement of thousands of lawsuits against Johnson & Johnson and three of the largest drug distributors — AmerisourceBergen,… Continue reading Dallas County to receive $2.3 million from Johnson & Johnson in opioid settlement

Oct 26, 2021

J&J strikes $297 million Texas-specific opioid settlement

J&J agrees to Texas-specific settlement tracking $5 billion national accord Drugmaker faced two potential trials in Texas in January The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback, which… Continue reading J&J strikes $297 million Texas-specific opioid settlement